Genzyme CorporateSearchGenzyme Websites
MPSI Disease Treatment Information for Patients and FamiliesMPSI Disease Treatment Information for Health Care Providers
MPSI
Health Care Professionals
Disease Overview
Genetics and MPS I
Severe and Attenuated
Symptoms & Symptom Management
Disease Progression
The MPS Family of Diseases
Lysosomal Storage Disorders
Diagnosing MPS I
Treatment Options
The MPS I Registry
Resources and Support

Skeletal System

General Physical Appearance
Nervous System

Skeletal System

Respiratory System

Auditory System

Cardiovascular System

Ocular System

Gastrointestinal System

Skeletal involvement in severe MPS I patients can be detected in the first year of life by radiological methods.[1][2] At that time, it is common to observe mild bone abnormalities, particularly within the hip, ovoid vertebrae, as well as widening of the ribs. Clinically, skeletal involvement does not become obvious until the age of 10-14 months when a gibbus deformity of the back or dorsolumbar kyphosis is observed (Image 1).

Gibbus deformity
Image 1 - Gibbus deformity

Courtesy of E. Kakkis, MD

Eventually, progressive skeletal dysplasia involving all bones is seen in all types of MPS I. The constellation of skeletal abnormalities is known as dysostosis multiplex.

The most notable features are defective centers of ossification of the vertebral bodies leading to ovoid vertebrae. The vertebrae become progressively flattened and beaked, often leading to spinal deformity. Complications may include spinal nerve entrapment, acute spinal injury, and atlanto-occipital instability. Long bones do not properly remodel and become short with irregular wide shafts and tilting of the epiphyses, leading to valgus and varus deformities. Typically the pelvis is poorly formed, with small femoral heads and coxa valga. Involvement of the femoral head leads to progressive and debilitating hip deformity. Clavicles are short, thickened and irregular. By three years of age there is little progression of physical (linear) growth. The joints often become stiffened by the age of two years and progressive arthropathy may affect joints. The hands may also take on a characteristic claw deformity resulting from both phalangeal dysostosis and
synovial thickening (Image 2).


Image 2 - Claw Hands

Courtesy of the National MPS Society

Carpal tunnel syndrome and interphalangeal joint involvement commonly lead to poor hand function in all forms of MPS I.[1][2] Carpal tunnel syndrome is often missed because its onset is insidious and often present with few or no symptoms except the naratrophy.

Joint replacement and specific neurosurgical approaches may be required to address spinal involvement, including atlanto-occipital stabilization. Physical therapy and its benefits in MPS I patients deserve further research.[2] Range of motion exercises appear to offer some benefits in preserving joint function. Once significant limitation has occurred, increased range of motion may not be achieved in the patient, but exercises may serve to minimize further limitation.

Next: Respiratory System

References:

1. Clarke, L.A. (1997) Clinical diagnosis of lysosomal storage diseases. In: Organelle Diseases. Clinical Features, Diagnosis, Pathogenesis and Management. Applegarth, D.A., Dimmick, J.E., and Hall, J.G. (eds.). Chapman and Hall Medical, London, pp. 37.

2. Neufeld, E.F., and Muenzer, J. (2001) The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K.W., and Vogelstein, B. (eds.). 8th edition, Vol. III. McGraw- Hill, Medical Publishing Division, pp. 3421.

Did you know...
In MPS I, glycosaminoglycan (GAG)-engorged cells accumulate and displace healthy normal cells in tissue and organs such as the liver and spleen, causing a host of signs, including skeletal deformities, coarse facial features, and an enlarged liver and spleen.
Watch Video
Alicia is a 16-year-old with MPS I who was diagnosed 10 years ago. Watch Alicia’s story to find out how she is handling life as a teenager living with MPS I.
Watch the Video
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142 USA
Phone: 617-768-9000 or
800-745-4447
Contact Genzyme